Krebs Biochemicals & Industries Limited

8-2-57718, PlotNo.34,3rd Floor, Maas Heights, Road N0.8, Banjara Hills, Hyderabad-S00034

CIN : 12411()TG1991PLCO1351

l-2tn February,2016

To,

The Manager,
Listing Department,
National Stock Exchange of India Limited,
Exchange Plaza, Bandra Kurla Complex,
Bandra (E), Mumbai- 400051.

The Manager,

Department of Corporate Relations,

BSE Limited,

Towers, Dalal Street,

Fort, Mumbai- 400001
PJ

Dear Sir/Madam,
Sub: Submission of Unaudited Financial Results for the quarter ended

3l't December,2OL5

Ref: Reg.33 of SEBt (Listing Obligations and Disclosure Requirements) Regulations ,20L5

We refer to the above captioned subject, we herewith submit you the unaudited financial results
and the Limited Review Report of the Statutory Auditors for the quarter and 9 months ended 31't
December, 2015, which was taken on record at the Board Meeting held on 12th February, 201.5.
Kindly take the same into your records.
Thanking You,
Yours Faithfully,

I- -pi;

Tel : 0091-(0) 40-66037777 Fax : 0091-(0) 40-66037755

E-mail : krebs@krebsbiochem.com, marketing@krebsbiochem.com URL : www.krebsbiochem.com

KREBS BIOCHEMICALS & INDUSTRIES LIMITED

CIN: L24ll0TGl991PLC0l35ll
Resd. Office: Plot No:38. 8-2-5778. Maas Heiebts. Road No:2. Baniara Hills. Hyderabad -500034

STAND ALONE FINANCIAL RDSULTS F'OR

.HE

OUARTER AND NINE MONTHS ENDED 3IST DECEMBER 2015

(Rs. In lacs
Previous Year
Ended
(6 Months)

Nine Months Etrded

Quarter Ended

Particulan
2.2015

fIInrD.lite.l)

PART - I
[ncome from Ooerations
a) Net Sales / Income from ODerations (Net ofExcise Dutv)
b) Other ODeratins Income
Total Income from oDerations (net)

tr

o
7
8

fArdiferl)

31.12.2015

31.12.2014

(l

{Ardifed)

31.03.201s
/A

2l

40.27

34

40.27

34.21

(8 48)

166 84

18.85

(241 64)

74.48

Cost of Material Consmed

Changes in invmtories offinished goods,

Emolovee bmefi ts exoense

L DeDreciation md Amortisation exoense
Other Mmufacnrrhs Exoenses
Other Exoenses
fotal Exoenses
lrofit / (Loss) from Operations before other income, finance costs and
)xceDtional items (1 - 2)

120.8
95.54

exceptional Items (3 + 4)
Finmce Costs

Protit / (Loss) from Ordinary Activities after Finance Costs but

before exceotional items (5 + 6)

(23

64

(227.e8)

109 08

6't 94

368.44

95.54

23.r1
(227.38'

185 67

187 I
90 76
213 82
677-38
(677.38)

286 62

248

82;70

160 3

60 0'1
369.sr

5'1

4'1.03

222 54

389.71

139.80

t.181.92

24 88
134'70
G7.80

(329,24)

(3ss.s0)

(139.801

(1,09r.s9)

67.80

63.89

l8r

(139.80)

(r,027.70)

69.61

Cther Income

Prolit / (Loss) from ordinary activitie before finance costs &

1'.75

99

2.38

60 76

(326.86)

(294.74)

356 66

20 90

407

0.25

25 17

(347.76)

(298.8r)

(r40.0s)

(r,0s2.87)

tt2
(676.26)

104

402 85

(1,079.r1)

68.5?

Exceptional Itmes:
a) Debit balances witten

off

(692.16

b) Waiver of Princioal of Bmk Loms & Others

3,625 17
(126.93

c) Deplerion in Value of Inventory

d) Amounts Written Back

9
0

1l

19.56

e) Profit on Sale of Food Division's Imovable Assets

f) Excess Provision ofErlier Period Written Back
Profit / (Loss) from Ordinarv activitis befor tax (7 + 8)
fax Exoeose

Net

Profit

Extra Ordinary Items

\et Profit / (Loss) for the Deriod

l5
t6

t7
l8

u07.671

(l40.05)

(1.031.02'

(11 + 12)

(784.01

84.t2
(39

99',,

(328.20)

(407.67)

(140.0s)

(1,03r.021

44.13

(784.01)

(328.20)

u07.67)

(140.0st

(1,03r.02)

44.13

(784.01r

(328.20)

(407.67)

(r40.0s)

(r,03r.02)

44.r3

(784.01)

1241 4:.

9s1.43

t306 43

95t.43

951.43

ihare of Profrt / (Loss) ofAssociates

Vlinority Interest
Net Profit / (Loss) afaer Taxes, minority Interest
[Loss) ofAssociates (f3 + f,|+
)

ffl

&

Share of ProfiU

Pajd-up Equity Share CaDital (Face Value Rs. I 0/- each

Reserve Excluding Revaluation Reserves as

1306 43

pu Balmce

Sheet ofprevious

b) Diluted

(2,637.91)

89 66

15 55

(328.20)

Accountins Year
Eaming Per Sbare (before extsaordinarry Items) (ofRs.10/- each) (not
re (D
Annualised)
) Rasic
19 (ii)

(126.93

t8 07

59 12

/ (Loss) from ordinary activitis after Tax (9 + 10)

I4

rdifed\

5.85

work-in-orop:ress md stock -in-tade

31.t2.2014

Exnenses

a
b

30.09.2015

(llna

3arning Per Share (after extaordinarry ltems)

(ofRs

10/-

NA

NA

NA

(1,407 e2)

NA

(2.5 I )

(3.28\

47

(3.28)

47

(7.89)
(7 89)

0.46
0.46

(8 24

(2 51

4',1

(7 8e)

046

(8.24

(7 8e)

046

(8 24

(8 24

each) (not

a) Basic

(2 5r

3.28)

@) Diluted

(2.5 1)

(3.28)

The above results have been reviewed by the Audit

NA

Comittee

(1

(r.47)

at its meeting held on 12th February, 2016 and approved by the Board of Directors of the Compmy at its meeting held

on l2th February, 2016.

fhe Above results are subjtrted to limited review by Compmy's Statutory Auditors.

Ihe Company is operating in

Figures have been regrouped, reananged wherever necessary

Ihe company has afloted 6.50 lacs equity shres md 6.80 lacs convertible wffimts on 03.10.2015 md the same was approved by shareholders on

'lace : Hyderabad
tafe
02 2016

one segment only hence no segment results have been disclosed

\I A

ltl 03.2015J4/i^te
J--

){'l

\---d)
-^hr.il \

./?- lufanaeinsD \ H\\ro'